Abstract
Breast cancer is the most prevalent malignant disease in women.
Amongst other risk factors such as age, life style, genetic factors and hormone
status, exposure to ionizing irradiation is a known risk factor. Markers
of radiation-associated breast cancer have been now identified at the
DNA-, miRNA- and protein levels providing the starting point for the identification
and personalized treatment of secondary, radiation-induced
breast cancer.